Biotechnology
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk‘s obesity drug Wegovy slashed the risk of serious heart problems by 20% in a large clinical trial – a landmark finding that could put more […]
Read More
Obesity drug Wegovy’s landmark trial result could ‘open up’ health insurance access, analyst says
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters LONDON — Popular weight-loss drug Wegovy could be made available under more health insurance schemes, after the results of a late-stage trial pointed to the drug’s efficacy in […]
Read More
Ohio voters flock to the polls with abortion rights at stake in GOP-backed rules change
A sign asking Ohioans to vote in support of Issue 1 sits above another sign advocating against abortion rights at an event hosted by Created Equal on Thursday, July 20, 2023, in Cincinnati, Ohio. Patrick Orsagos | AP The people of Ohio on Tuesday are voting on a ballot initiative that would make it significantly […]
Read More
Novavax shares jump after Covid vaccine maker posts surprise quarterly profit
Medical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on December 2, 2021. Jakub Porzycki | NurPhoto | Getty Images Shares of Novavax jumped as much as 20% in premarket trading Tuesday after the Covid vaccine maker reported a surprise second-quarter profit. The results come […]
Read More
Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%
Sopa Images | Lightrocket | Getty Images Eli Lilly on Tuesday raised its full-year guidance as second-quarter profit jumped 85% from the same period a year ago on strong sales from the pharmaceutical giant’s drug pipeline. The company now expects full-year revenue of between $33.4 billion to $33.9 billion, up from a previous forecast of […]
Read More
Red Cross ends blood-donation restrictions that singled out gay and bisexual men
A worker with Vitalant places a needle on the arm of a blood donor as he prepares to donate blood during the Hoboken community Vitalant blood drive held at Hoboken Rec Center on June 25, 2021 in Hoboken, New Jersey. Michael M. Santiago | Getty Images The American Red Cross is now allowing gay and […]
Read More
Sage Therapeutics stock plunges more than 50% after FDA denies wider use of postpartum depression drug
In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a smartphone and on a pc screen. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Shares of Sage Therapeutics fell more than 50% on Monday after the Food and Drug Administration approved the biotech company’s oral drug zuranolone for […]
Read More
Pfizer limits distribution of some drugs from North Carolina plant damaged by tornado
The roof of a Pfizer facility shows heavy damage after a tornado passed the area in Rocky Mount, North Carolina, July 19, 2023. ABC Affiliate WTVD | via Reuters Pfizer is limiting the distribution of some drugs manufactured at its plant in Rocky Mount, North Carolina after the facility was struck by a tornado last […]
Read More
Infant RSV shot faces final hurdle at CDC, could be available by fall
A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022. Heiko Becker | Reuters Americans may soon have access to a shot that protects babies from respiratory syncytial virus, or RSV, the leading cause of hospitalization among infants in the U.S. A panel […]
Read More
Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales
Artur Widak | Nurphoto | Getty Images Shares of Moderna rose Thursday after the biotech company hiked its full-year outlook for its Covid vaccine, its only marketable product, despite reporting a quarterly loss and sharp drop in revenue. Here are Moderna’s results: Loss per share: $3.62 (That may not be comparable to the $4.04 expected by […]
Read More